Ketamine assisted psychotherapy (KAP) has received increased attention in the media, academic, and professional circles ever since the FDA approved its use for therapeutic treatment in 2019. Perhaps your clients have been expressing interest in KAP, or you as a clinician have questions about what it is and how it's being used. This webinar will give an overview of KAP and how it works, help therapists identify clients who might be a good candidate for KAP, and discuss clinical and ethical considerations that come along with providing this type of therapy.